2 June 2023
CAP-XX Limited
("CAP-XX" or "the Company")
Result of General Meeting
CAP-XX Limited (AIM: CPX), a global leader in prismatic, high-power supercapacitors, announces that the Resolution put to shareholders at the Company's General Meeting held earlier today was duly passed.
Application has been made to the London Stock Exchange for a total of 129,243,754 new Ordinary Shares ("New Ordinary Shares"), issued in relation to the Placing, the Subscription and the Retail Offer, to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective, and dealings in the New Ordinary Shares will commence, at 8:00 a.m. BST on 6 June 2023. Following Admission, the total number of Ordinary Shares and voting rights in the Company will be 716,014,958.
Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the announcement issued by the Company on 3 May 2023 unless otherwise defined herein.
For further information contact:
CAP-XX Limited
Pat Elliott (Chairman)
Lars Stegmann (Chief Executive Officer)
+61 (0) 2 9157 0000
Allenby Capital (Nominated Adviser and Joint Broker)
David Hart / Piers Shimwell (Corporate Finance)
Tony Quirke (Sales and Corporate Broking)
+44 (0) 20 3328 5656
Cenkos Securities plc (Joint Broker)
Neil McDonald / Pearl Kellie
+44 (0) 13 1220 6939
Kreab (Financial PR)
Robert Speed
+44 (0) 20 7074 1800
More information is available at www.cap-xx.com
Notes to Editors:
CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package.These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDROMEAXKAEDDDEEA